Reports - Biochips Market
Semiconductor & ElectronicsBiochips Market
Biochips Market Size and Projected Growth Through 2035 by Product Types (DNA Chips, Lab-on-Chip, Protein Chips, Tissue Arrays, Others) by Applications (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, Other applications) by Fabrication Techniques (Microarrays, Microfluidics) by End Users (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centres, Academic & Research Institutes, Other End Users) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Biochips Market - Segment Analysis
1. Overview
2. Global Biochips Market, 2021 - 2035 (USD Million)
3. Global Biochips Market - by Product Types
3.1. By DNA Chips
3.2. By Lab-on-Chip
3.3. By Protein Chips
3.4. By Tissue Arrays
3.5. By Others
4. Global Biochips Market - by Applications
4.1. By Drug Discovery & Development
4.2. By Disease Diagnostics
4.3. By Genomics
4.4. By Proteomics
4.5. By Agriculture
4.6. By Other applications
5. Global Biochips Market - by Fabrication Techniques
5.1. By Microarrays
5.2. By Microfluidics
6. Global Biochips Market - by End Users
6.1. By Biotechnology & Pharmaceutical Companies
6.2. By Hospitals & Diagnostics Centres
6.3. By Academic & Research Institutes
6.4. By Other End Users
7. Global Biochips Market - by region
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Market comparative analysis
Chapter 4 North America Biochips Market - Segment Analysis
1. Overview
2. North America Biochips Market, 2021 - 2035 (USD Million)
3. North America Biochips Market - by Product Types
3.1. By DNA Chips
3.2. By Lab-on-Chip
3.3. By Protein Chips
3.4. By Tissue Arrays
3.5. By Others
4. North America Biochips Market - by Applications
4.1. By Drug Discovery & Development
4.2. By Disease Diagnostics
4.3. By Genomics
4.4. By Proteomics
4.5. By Agriculture
4.6. By Other applications
5. North America Biochips Market - by Fabrication Techniques
5.1. By Microarrays
5.2. By Microfluidics
6. North America Biochips Market - by End Users
6.1. By Biotechnology & Pharmaceutical Companies
6.2. By Hospitals & Diagnostics Centres
6.3. By Academic & Research Institutes
6.4. By Other End Users
Chapter 5 Europe Biochips Market - Segment Analysis
1. Overview
2. Europe Biochips Market, 2021 - 2035 (USD Million)
3. Europe Biochips Market - by Product Types
3.1. By DNA Chips
3.2. By Lab-on-Chip
3.3. By Protein Chips
3.4. By Tissue Arrays
3.5. By Others
4. Europe Biochips Market - by Applications
4.1. By Drug Discovery & Development
4.2. By Disease Diagnostics
4.3. By Genomics
4.4. By Proteomics
4.5. By Agriculture
4.6. By Other applications
5. Europe Biochips Market - by Fabrication Techniques
5.1. By Microarrays
5.2. By Microfluidics
6. Europe Biochips Market - by End Users
6.1. By Biotechnology & Pharmaceutical Companies
6.2. By Hospitals & Diagnostics Centres
6.3. By Academic & Research Institutes
6.4. By Other End Users
Chapter 6 Asia Pacific Biochips Market - Segment Analysis
1. Overview
2. Asia Pacific Biochips Market, 2021 - 2035 (USD Million)
3. Asia Pacific Biochips Market - by Product Types
3.1. By DNA Chips
3.2. By Lab-on-Chip
3.3. By Protein Chips
3.4. By Tissue Arrays
3.5. By Others
4. Asia Pacific Biochips Market - by Applications
4.1. By Drug Discovery & Development
4.2. By Disease Diagnostics
4.3. By Genomics
4.4. By Proteomics
4.5. By Agriculture
4.6. By Other applications
5. Asia Pacific Biochips Market - by Fabrication Techniques
5.1. By Microarrays
5.2. By Microfluidics
6. Asia Pacific Biochips Market - by End Users
6.1. By Biotechnology & Pharmaceutical Companies
6.2. By Hospitals & Diagnostics Centres
6.3. By Academic & Research Institutes
6.4. By Other End Users
Chapter 7 Latin America Biochips Market - Segment Analysis
1. Overview
2. Latin America Biochips Market, 2021 - 2035 (USD Million)
3. Latin America Biochips Market - by Product Types
3.1. By DNA Chips
3.2. By Lab-on-Chip
3.3. By Protein Chips
3.4. By Tissue Arrays
3.5. By Others
4. Latin America Biochips Market - by Applications
4.1. By Drug Discovery & Development
4.2. By Disease Diagnostics
4.3. By Genomics
4.4. By Proteomics
4.5. By Agriculture
4.6. By Other applications
5. Latin America Biochips Market - by Fabrication Techniques
5.1. By Microarrays
5.2. By Microfluidics
6. Latin America Biochips Market - by End Users
6.1. By Biotechnology & Pharmaceutical Companies
6.2. By Hospitals & Diagnostics Centres
6.3. By Academic & Research Institutes
6.4. By Other End Users
Chapter 8 Middle East & Africa Biochips Market - Segment Analysis
1. Overview
2. Middle East & Africa Biochips Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Biochips Market - by Product Types
3.1. By DNA Chips
3.2. By Lab-on-Chip
3.3. By Protein Chips
3.4. By Tissue Arrays
3.5. By Others
4. Middle East & Africa Biochips Market - by Applications
4.1. By Drug Discovery & Development
4.2. By Disease Diagnostics
4.3. By Genomics
4.4. By Proteomics
4.5. By Agriculture
4.6. By Other applications
5. Middle East & Africa Biochips Market - by Fabrication Techniques
5.1. By Microarrays
5.2. By Microfluidics
6. Middle East & Africa Biochips Market - by End Users
6.1. By Biotechnology & Pharmaceutical Companies
6.2. By Hospitals & Diagnostics Centres
6.3. By Academic & Research Institutes
6.4. By Other End Users
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Thermo Fisher Scientific Inc. (U.S.)
2. Abbott Laboratories (U.S.)
3. Agilent Technologies Inc. (U.S.)
4. PerkinElmer Inc. (U.S.)
5. Fluidigm Corporation (U.S.)
6. Illumina Inc. (U.S.)
7. GE Healthcare (U.S.)
8. Bio-Rad Laboratories Inc. (U.S.)
9. F. Hoffmann-La Roche AG (Switzerland)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By